Supermarket and Web-Based Intervention Targeting Nutrition (SuperWIN) for Cardiovascular Risk Reduction

NCT ID: NCT03895580

Last Updated: 2022-02-22

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

267 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-04-08

Study Completion Date

2021-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The Supermarket and Web-based Intervention targeting Nutrition (SuperWIN) for cardiovascular risk reduction is a novel, randomized controlled trial aimed at increasing diet quality and decreasing cardiovascular risk. SuperWIN will deliver individualized, nutrition education at the point-of-purchase (POP), either in the aisles of the physical store or via online shopping platforms coupled with other modern software tools.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study is designed to test whether individualized, POP nutrition education can improve dietary quality. The two interventions to be evaluated in SuperWIN will utilize either an in-store POP education strategy or a combined online/in-store POP education strategy in participants with at least one cardiovascular disease risk factor. The POP education interventions will be enhanced with sophisticated, provider- and participant-facing, food-purchasing metrics, a novel counseling tool that here-to-fore has not been studied in regard to changing food shopping behavior. The primary outcome measure is the Dietary Approaches to Stop Hypertension (DASH) score, a measure of adherence to the DASH dietary pattern. The study is well-powered to test at Day 90: 1) whether any POP education intervention strategy (both intervention arms pooled) improves the DASH score compared to the control arm and 2) whether an improvement in DASH score depends on the POP education strategy utilized.

Both POP education strategies will be delivered within a supermarket-based retail clinic and will utilize the aisles and products of the supermarket. The interventions will be delivered by a registered dietitian nutritionist (RDN). The online portion of the combined online/in-store education POP strategy will include online grocery shopping, online recipe resources, a grocery pickup or home delivery service, and a phone application to better select healthy foods.

Both strategies will be offered in addition to a "standard of care" medical nutrition therapy session. The DASH dietary pattern has been empirically tested and shown to favorably modify blood pressure, blood cholesterol, insulin sensitivity, and weight status.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Obesity Hypertension Hyperlipidemias Diet Modification

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Due to COVID-19, recruitment and all in-person visits had to be temporarily stopped due to safety concerns in March 2020. Due to this stoppage, 20 randomized subjects could not complete their in-person study visits or data collection as per protocol. These 20 subjects will be excluded from all primary analyses, including the primary endpoint. Recruitment and in-person visits resumed in June 2020. To account for the exclusion of these 20 subjects, we randomized 267 subjects by the end of the study in order to have 247 subjects available for the primary analyses (e.g. 267-20= 247). A prespecified COVID impact analysis has been included in the statistical analysis plan.
Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group 1

Medical nutrition therapy session with no further dietary counseling throughout the study.

Group Type NO_INTERVENTION

No interventions assigned to this group

Group 2

Medical nutrition therapy session plus in-store point-of-purchase (POP) education.

Group Type EXPERIMENTAL

In-store POP education

Intervention Type OTHER

Six in-store nutrition counseling sessions with a registered dietitian nutritionist.

Group 3

Medical nutrition therapy session plus combined in-store/online point-of-purchase (POP) education.

Group Type EXPERIMENTAL

In-store POP education

Intervention Type OTHER

Six in-store nutrition counseling sessions with a registered dietitian nutritionist.

Online POP education

Intervention Type OTHER

Education on the use of an online grocery shopping, an online recipe tool, a grocery pickup service, a home grocery delivery service, and a phone application that promotes healthy food selection.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

In-store POP education

Six in-store nutrition counseling sessions with a registered dietitian nutritionist.

Intervention Type OTHER

Online POP education

Education on the use of an online grocery shopping, an online recipe tool, a grocery pickup service, a home grocery delivery service, and a phone application that promotes healthy food selection.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Age ≥21 to ≤75 years on the start date of the study (Day 0)
2. Speak, write, read English fluently
3. In-person outpatient visit with a UC Health primary care network (PCN) provider within the last 12 months
4. Major food planner of their household, which may include planning, purchasing, and/or preparing greater than 50% of the meals or foods consumed at home
5. Existing shopper at a study site Kroger (≥50% of grocery store food dollars spent at Kroger) with a Kroger Loyalty ID number
6. Willing to use a new individual Kroger Loyalty ID number for the duration of the study
7. Access to a home desktop or laptop computer with reliable internet access
8. Access to an email account that can be used for the duration of the study
9. Able to independently purchase and prepare food:

1. Reliable transportation to participating Kroger store
2. Ability to stand for significant periods of time to grocery shop and prepare food at home
3. Tools and equipment needed to prepare own food at home, such as a kitchen equipped with basic cooking tools (e.g. burner, pan, spatula, sink)
10. Presence of a cardiovascular risk factor(s) (at least one):

1. Hypertension (defined by one of the following):

* Blood pressure measurement: systolic blood pressure (SBP) 130-189 mm Hg and/or diastolic blood pressure (DBP) 80-109 mm Hg (at Visit #1)
* Current treatment with an oral medication prescribed by a physician for blood pressure lowering (defined by one of the following):

1. Beta blockers
2. Diuretics (e.g. thiazide or thiazide-like diuretics, loop diuretics, aldosterone antagonists, potassium-sparing diuretics)
3. Angiotensin-converting enzyme inhibitors
4. Angiotensin II receptor blockers
5. Direct renin inhibitors (i.e. aliskiren)
6. Calcium channel blockers (dihydropyridine and nondihydropyridine)
7. Calcium alpha2-agonist and other centrally acting drugs (e.g. clonidine)
8. Direct vasodilators (e.g. hydralazine)
2. Body-mass index (BMI) measurement ≥30 kg/m2 (at Visit #1)
3. Hypercholesterolemia (defined by one of the following):

* Low density lipoprotein cholesterol (LDL-C) 130-189 mg/dl (at Visit #1)
* Current treatment with a medication prescribed by a physician for hypercholesterolemia (defined by one of the following):

1. Statins
2. Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors
3. Absorption inhibitors (i.e. ezetimibe)
4. Fibrates
5. High-dose niacin (≥1 g per day)
6. Bile acid sequestrants (e.g. cholestyramine)

Exclusion Criteria

1. Unwillingness or inability to modify current diet
2. Actively engaged in another dietary intervention or taking a weight-loss supplement
3. SBP ≥190 mm Hg or DBP ≥110 mm Hg (at Visit #1)
4. Low-density lipoprotein cholesterol (LDL-C) ≥190 mg/dl, triglycerides (TG) ≥600 mg/dl, or glucose ≥400 mg/dl (at Visit #1)
5. Evidence of prior diagnosis of severe chronic kidney disease (CKD) defined by electronic health record codes for dialysis, CKD Stage 4 or 5 and/or last estimated glomerular filtration rate (eGFR) ≤30 ml/min/1.732 \[based on Modification of Diet in Renal Disease (MDRD) formula\]
6. Active cancer other than non-melanoma skin cancers (i.e. basal cell carcinoma or squamous cell carcinoma)
7. Diagnosis of celiac disease, ulcerative colitis, or Crohn's disease
8. High risk for alcohol use disorder:

1. ≥21 drinks a week (men)
2. ≥14 drinks a week (women)
9. Women who are pregnant or plan to become pregnant within the next 6 months from the start of the study (Day 0)
10. Food allergies requiring a specialized diet, including allergies to dairy products, eggs, peanuts, tree nuts, soy, gluten-containing wheat and grains, fish, and shellfish
11. Previous visit at TLC for diet counseling
12. Previous use of the Kroger's online shopping platform (Kroger.com or the Kroger app)
13. Participant lives greater than 20 miles from any participating Kroger study store (defined by zip codes)
14. Women, Infants, and Children (WIC) beneficiaries in their household
Minimum Eligible Age

21 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

The Kroger Company

UNKNOWN

Sponsor Role collaborator

Children's Hospital Medical Center, Cincinnati

OTHER

Sponsor Role collaborator

University of Cincinnati

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Dylan Steen

Director of Clinical Trials and Population Health Research, UC Heart, Lung, and Vascular Institute

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Dylan L Steen, MD, MS

Role: PRINCIPAL_INVESTIGATOR

University of Cincinnati

Sarah C Couch, RD, PhD

Role: PRINCIPAL_INVESTIGATOR

University of Cincinnati

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Cincinnati Medical Center - UC Health

Cincinnati, Ohio, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

References

Explore related publications, articles, or registry entries linked to this study.

Steen DL, Helsley RN, Bhatt DL, King EC, Summer SS, Fenchel M, Saelens BE, Eckman MH, Couch SC. Efficacy of supermarket and web-based interventions for improving dietary quality: a randomized, controlled trial. Nat Med. 2022 Dec;28(12):2530-2536. doi: 10.1038/s41591-022-02077-7. Epub 2022 Dec 1.

Reference Type DERIVED
PMID: 36456831 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

20168163

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Small Steps for Big Changes - Recipe for Health
NCT05962983 NOT_YET_RECRUITING NA
Digital Nutrition Intervention for Older Adults
NCT05220631 ACTIVE_NOT_RECRUITING NA